Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Biogen Inc. News

Stock Market Today - 5/3: Stocks End Higher Amid Fed Rate Hike Bets; Treasury Yields Ease

Stocks finish higher Tuesday as the Federal Reserve begins its two-day policy meeting amid bets on faster and deeper near-term rate hikes.

Biogen Stock Gains After Q1 Earnings Miss; CEO Michel Vounatsos Exits

"I will be leaving at a time of promise for Biogen, with noteworthy potential for value creation," said departing CEO Michel Vounatsos.

Should Biogen Investors Be Worried About Its Alzheimer's Drug?

A Medicare policy decision might hurt sales of this biotech giant's Alzheimer's drug.

Biogen's ALS Drug Won't Move Forward After Trial Failures

Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

Breaking News

Crypto: 46,000 People Lost $1 Billion to Cons in 15 Months

Scammers are taking advantage of the crypto craze to line their pockets, FTC says.

American Nightmare: It Costs How Much More to Buy a Home?

Sky-high home prices are driving younger buyers out of the market.

Musk Endorses Fellow Billionaire in Los Angeles Mayoral Race

The CEO of Tesla has become one of the most influential voices in the world.

The Roblox Gaming Platform No Longer Sees Clearly

Roblox's shares are down 71% since January.